Keywords: BRCA1; CDKN2A; EUS, endoscopic ultrasound; MIS, melanoma in situ; MRCP, magnetic resonance cholangiopancreatography; MRI, magnetic resonance imaging; SCC, squamous cell carcinoma; cancer predisposition; cancer screening; familial melanoma; multiple melanoma; multiple pathogenic variants.